TJO-083

DRUG2 trials

Sponsors

Taejoon Pharmaceutical Co., Ltd.

Conditions

Dry EyeDry Eye Syndromes

Phase 1

Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients

Taejoon Pharmaceutical Co., Ltd.Dry Eye Syndromes

Start: 2021-10-14End: 2023-06-30Target: 98Updated: 2022-04-26

Phase 3

Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients

CompletedNCT06427031

Taejoon Pharmaceutical Co., Ltd.Dry Eye, Dry Eye Syndromes

Start: 2023-07-14End: 2024-07-03Updated: 2025-04-22